Skip to main content

Table 4 Median CPI-adjusted MPR of originator and generic brands in all sectors surveyed in Qatar and Lebanon

From: Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: surveys in Qatar and Lebanon

 

Qatar

Lebanon

Public (n = 5)

Private (n = 6)

Other (n = 4)

Private (n = 6)

OB

LPG

OB

LPG

OB

LPG

OB

LPG

Median MPR (IQRa)

1.44 (0.45–2.33)

0.01 (0.01–0.01)

21.60 (6.42–40.43)

26.50 (22.70–29.26)

26.71 (14.44–46.04)

29.52 (25.11–33.81)

12.37 (3.30–32.57)

5.82 (1.85–13.56)

Min MPR

0.09

0.01

0.72

0.40

0.72

13.28

0.52

0.32

Max MPR

9.68

0.01

67.73

44.10

67.73

44.10

59.73

41.13

Medicines included

23

1

19

9

14

4

20

17

  1. Note: Min minimum, Max maximum
  2. aInterquartile range